Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Human Reproduction Update|July 13, 2007
An update of luteal phase support in stimulated IVF cyclesH M Fatemi, B Popovic-Todorovic, E Papanikolaou, et al.
Reproductive Biomedicine Online|September 4, 2008
Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donorsH M Fatemi, B Popovic-Todorovic, P Donoso, et al.
Reproductive Biomedicine Online|April 13, 2010
Intramyometrial ectopic pregnancy in an ICSI patient following uterine artery embolizationM Leyder, M De Vos, B Popovic-Todorovic, et al.
Case Reports in Genetics|September 21, 2017
What Drives Embryo Development? Chromosomal Normality or Mitochondria?A Bayram, I Elkhatib, A Arnanz, et al.
Human Reproduction (Oxford, England)|July 22, 2006
Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trialH M Fatemi, E M Kolibianakis, M Camus, et al.
Human Reproduction Update|July 8, 2011
Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysisD Kyrou, E M Kolibianakis, H M Fatemi, et al.
Human Reproduction (Oxford, England)|January 18, 2007
Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of conceptH M Fatemi, C Bourgain, P Donoso, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 20, 2012
The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cyclesD Kyrou, M Al-Azemi, E G Papanikolaou, et al.
Reproductive Biomedicine Online|November 9, 2005
Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitorH M Fatemi, H A Al-Turki, E G Papanikolaou, et al.
Human Reproduction (Oxford, England)|August 13, 2009
Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist?D Kyrou, B Popovic-Todorovic, H M Fatemi, et al.
Pageof 4